Kite Pharma hits its Q1 deadline on filing a BLA for its pioneering CAR-T, posts improved data
With the clock ticking down the final hours of Q1, Kite Pharmaceuticals $KITE has kept its pledge to file an application for its pioneering CAR …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.